This is a snippet of the transcript.Contact Salesto get full access.
There were many discussions about whether it was worth establishing an in-house team with 3D artists and clinical experts to create these renderings. The idea was to see if it was worth taking some business away from vendors, as we were paying a lot for that, and whether the cost justified doing it in-house. There was also exploration around finding other vendors to create a competitive situation and get better economics. This was underway before I left, but from my last discussions with industry players, it still sounds like they are heavily reliant on existing arrangements.
This is a snippet of the transcript.Contact Salesto get full access.
I think they've attempted to do something, but Intuitive is predominantly a hardware company. That's how they started. It's led and driven by engineers, and that's how decisions are made, unfortunately. They've tried their hand at many things and stumbled in many areas. For example, the XR team I've mentioned—I haven't seen a single product come out. I'm not sure what they do. They probably have 50 or 60 people, and you wonder what they actually do there. Years have passed, and I haven't seen a single product.
This is a snippet of the transcript.Contact Salesto get full access.
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities. The views of the executive expressed in the Content are those of the expert and they are not endorsed by, nor do they represent the opinion of In Practise. In Practise makes no representations and accepts no liability for the Content or for any errors, omissions, or inaccuracies will in no way be held liable for any potential or actual violations of laws, including without limitation any securities laws, based on Information sent to you by In Practise.
© 2025 IP 1 Ltd. All rights reserved.